Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket

Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) rose sharply in today’s pre-market trading.

4DMT presented interim data from randomized Phase 2 PRISM clinical trial of intravitreal 4D-150 demonstrating favorable tolerability & clinical activity in wet AMD.

4D Molecular Therapeutics shares jumped 20.1% to $21.01 in pre-market trading

Here are some other stocks moving in pre-market trading.

Gainers

Losers

 

Now Read This: McDonald's, Caterpillar And 3 Stocks To Watch Heading Into Monday

 

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.